Progressive Exposure of E-Neoantigen Associated with Degradation of Crosslinked Fibrin by Plasmin In Vitro

Summary

Fragment E-neoantigen (Eneo) is a specific marker of structural and conformational changes associated with the degradation of fibrinogen and its related proteins. In this study Eneo expression was followed during the plasmin degradation of crosslinked (XL) fibrin in vitro, utilizing double antibody radioimmunoassay. Eneo was progressively exposed as degradation proceeded and its expression was associated with the liberation of high molecular weight fragments from XL-fibrin, their degradation into fragments DD and E, and the partial degradation of fragment E itself. An isolated protein fraction containing early high molecular weight fragments (MW >360000 d) and a fraction containing fragments YY and DY expressed approximately 170 times and 15 times less Eneo per protein respectively compared to the fragment E standard. XL- fibrin fragment E isolated from 1-hr plasmin digest expressed approximately 8 times less Eneo than fragment E isolated from 24-hr digest, indicating increased exposure of Eneo during fragment E degradation. Eneo expression of this terminal fragment E was comparable to fibrinogen fragment E. As expected, fragment DD had no Eneo immunoreactivity.

Key words

Fragment E-neoantigen - Plasmin degradation of crosslinked fibrin - Radioimmunoassay

• References

• 1 Mander VJ, Shulman NR, Carroll WR. Physicochemical and immunological characterization. J Biol Chem 1969; 244: 2111-2119
• 2 Plow EF, Hougie C, Edgington TS. Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. J Immunol 1971; 107: 1496-1500
• 3 Plow EF, Edgington TS. A cleavage-associated neoantigenic marker for a γ chain site in the NH₂-terminal aspect of the fibrinogen molecule. J Biol Chem 1975; 250: 3386-3392
• 4 Plow E, Edgington TS. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo J Clin Invest 1973; 52: 273-282
• 5 Edgington TS, Plow EF. Conformational and structural modulation of the NH₂-terminal regions of fibrinogen and fibrin associated with plasmin cleavage. J Biol Chem 1975; 250: 3393-3398
• 6 Chen JP, Reyniers JP, Williams TK. Progressive exposure of E-neoantigenic site associated with the plasmin cleavage of fibrinogen. Circulation 1982; 66: 2-181
• 7 Hudry-Clergeon G, Paturel L, Suscillon M. Identification d’un complexe (D-D)… E dans les produits de degradation de la fibrine bovine stabilisée par le Facteur XIII. Pathol Biol (Paris) 1974; 22 suppl 47-52
• 8 Gaffney PJ, Lane DA, Kakkar VV, Brasher M. Characterisation of a soluble D dimer-E complex in crosslinked fibrin digests. Thromb Res 1975; 7: 89-99
• 9 Kopec M, Teisseyre E, Dudek-Wojciechowska G, Kloczewiak M, Pankiewicz A, Latallo ZS. Studies on the “double D” fragment from stabilized bovine fibrin. Thromb Res 1973; 2: 283-291
• 10 Pizzo SV, Taylor Jr LM, Schwartz ML, Hill RL, McKee PA. Subunit structure of fragment D from fibrinogen and cross-linked fibrin. J Biol Chem 1973; 248: 4584-4590
• 11 Budzynski AZ, Marder VJ, Parker ME, Shames P, Brizuela BS, Olexa SA. Antigenic markers on fragment DD, a unique plasmic derivative of human crosslinked fibrin. Blood 1979; 54: 794-804
• 12 Slade CL, Pizzo SV, Taylor Jr LM, Steinman HM, McKee PA. Characterization of Fragment E from fibrinogen and cross-linked fibrin. J Biol Chem 1976; 251: 1591-1596
• 13 Chen JP, Schulof RS. Radioimmunoassay of fibrinogen-fibrin degradation products: Assay for fragment E-related neoantigen - Methodological aspects. Thromb Res 1979; 16: 601-615
• 14 Alkjaersig N, Davies A, Fletcher A. Fibrin and fibrinogen proteolysis products: Comparison between gel filtration and SDS polyacrylamide electrophoresis analysis. Thromb Haemostas 1977; 38: 524-535
• 15 Reganon E, Vila V, Aznar J. Identification of high molecular weight derivatives of plasmic digests of cross-linked human fibrin. Thromb Haemostas 1978; 40: 368-376
• 16 Francis CW, Marder VJ, Martin SE. Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes. Blood 1980; 56: 456-464
• 17 Gaffney PJ, Joe F, Mahmoud M. Giant fibrin fragments derived from crosslinked fibrin: Structure and clinical implication. Thromb Res 1980; 20: 647-662
• 18 Lorand L, Gotoh T. Fibrinoligase. The fibrin stabilizing factor system Methods Enzymol 1970; 19: 770-782
• 19 Olexa SA, Budzynski AZ. Primary soluble plasmic degradation product of human cross-linked fibrin. Isolation and stoichiometry of the (DD) E complex Biochemistry 1979; 18: 991-995
• 20 Weber K, Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem 1969; 244: 4406-4412
• 21 Francis CW, Marder VJ, Martin SE. Detection of circulating crosslinked fibrin derivatives by a heat extraction-SDS gradient gel electrophoretic technique. Blood 1979; 54: 1282-1295
• 22 Chen JP, Shurley HM, Vickroy MF. A facile separation of fragments D and E from the fibrinogen/fibrin degradation products of three mammalian species. Biochem Biophys Res Commun 1974; 61: 66-71
• 23 McDonagh RP, McDonagh J, Blomback B. Isolation and characterization of the S-carboxymethyl derivatives of crosslinked and noncrosslinked human fibrin. Proc Natl Acad Sci USA 1972; 69: 3648-3652
• 24 Francis CW, Marder VJ, Barlow GH. Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure J Clin Invest 1980; 66: 1033-1043
• 25 Graeff H, Hafter R, Bachmann L. Subunit and macromolecular stucture of circulating fibrin from obstetric patients with intravascular coagulation. Thromb Res 1979; 16: 313-328
• 26 Whitaker AN, Rowe EA, Masci PP, Gaffney PJ. Identification of a D dimer-E complex in disseminated intravascular coagulation. Thromb Res 1980; 18: 453-459
• 27 Chen JP, Hanna WT, Williams TK, Krauss S. Radioimmunoassay of fragment E-related neoantigen: Validation studies and clinical application. Br J Haematol 1984; 57: 133-144